Phase II, 12-week, multicentre, randomised trial investigating ETC 1002 in patients with hypercholesterolaemia with or without high triglycerides.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2015
At a glance
- Drugs Bempedoic acid (Primary)
- Indications Hypercholesterolaemia
- Focus Biomarker; Therapeutic Use
- Sponsors Esperion Therapeutics
- 12 Jun 2013 Results published in the Journal of the American College of Cardiology.
- 26 Mar 2012 Results were reported at the 61st Annual American College of Cardiology Meeting, according to an Esperion Therapeutics media release.
- 01 Oct 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History